Enduring Materials
To extend the program education to a national audience, various interactive, enduring, on-demand activities will be made available. These enduring activities include:
Educational Resources
- Evaluating measurable residual disease in acute myeloid leukemia
- Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission
- Hematopoietic stem cell transplantation for patients with AML in first complete remission
- Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
- Prognostic Mutations in Myelodysplastic Syndrome After Stem-Cell Transplantation
- Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
- CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
- Durable Remissions With Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
Virtual Summit
The tumor board at one of the live summits will be recorded and turned into an interactive online activity, with content divided into digestible sections that mirror the agenda. In addition, a recording of the summit breakout sessions will be synchronized with slides to create webcasts. The content will include case-based discussions mixed with didactic portions. Learners will engage with the content by responding to multiple-choice questions throughout the activity.
These educational activities will be available at www.ashacademy.org in March 2019.
Simulated Cases for Clinicians
Two simulated, case-based activities will allow health care professionals to virtually manage patients with MDS or AML. Each activity will require the participant to work through the case by obtaining a patient history, considering differential diagnoses, ordering and interpreting laboratory tests, and more. This virtual experience will help the clinician transfer the learned behavior into his/her practice to improve patient care.
These cases are available at www.ashacademy.org.
CheckPath Simulations for Pathologists
The American Society of Clinical Pathology (ASCP) will review and update CheckPath cases on AML and MDS. CheckPath is an online virtual slide/digital image-based assessment program. It uses an innovative virtual microscope that allows for extensive image manipulation and annotation and provides assessment feedback for individual and laboratory comparison.
These free simulations are available at:
- CheckPath AML 2018 - https://www.ascp.org/store/productlisting/productdetail?productId=102421494
- CheckPath MDS 2018 - https://www.ascp.org/store/productlisting/productdetail?productId=102421324
“Speed Talk” Series for Hematology/Oncology APPs
Content developed for the live educational programs will be adapted to create an online “Speed Talk” series from the Oncology Nursing Society (ONS). For this series, whiteboard presentations will be designed to address the specific gaps among advance practice providers and nurses.
These videos area available at
https://www.ons.org/courses/amlmds-matter-educational-video-series-nurses-and-apps.